Hologic Inc. reported a total revenue of $1.005 billion for the second quarter of fiscal 2025, marking a decrease compared to the previous year. Despite macroeconomic and policy challenges, the company made strides in reinvigorating growth and showcased the reliability and adaptability of its business model. The company highlighted its strong employee engagement, which remains at a high level, and its strategic and financial flexibility, underpinned by a robust balance sheet and cash flows. This quarter, Hologic generated $169.5 million in operating cash, driven by its durable, market-leading brands.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。